Amneal Pharmaceuticals Inc Class A (AMRX)

Investing Cash Flow

-$122.74M

Quarterly · Period ending: · USD

AMRX logo

AMRX Investing Cash Flow

Latest reported-$122.74M
AMRX Quarterly Cash from Investing (-$36.06M → -$122.74M)
High-resolution chart · PNG

AMRX investing cash flow history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Amneal Pharmaceuticals Inc Class A Investing Cash Flow — Quarterly (USD)
Period endingInvesting Cash Flow (USD)
-122,742,000
-21,710,000
-45,454,000
-22,464,000
-26,547,000
-17,798,000
-16,059,000
-20,712,000
-6,465,000
-19,760,000
-31,692,000
-13,476,000
-12,284,000
-11,737,000
-11,466,000
-49,332,000
-16,116,000
-97,395,000
-86,969,000
-11,633,000
-82,887,000
-12,693,000
-31,795,000
-14,782,000
-8,927,000
-262,042,000
-4,767,000
29,982,000
-23,329,000
-21,466,000
5,321,000
-40,775,000
-341,425,000
-19,499,000
-8,901,000
-35,041,000
-29,855,000
-24,757,000
-36,063,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.